# NOPHO-AML 2004 Study for Children With Acute Myeloid Leukemia

> **NCT00476541** · PHASE3 · COMPLETED · sponsor: **University of Aarhus** · enrollment: 250 (estimated)

## Conditions studied

- Acute Myeloid Leukemia

## Interventions

- **DRUG:** Gemtuzumab ozogamicin

## Key facts

- **NCT ID:** NCT00476541
- **Lead sponsor:** University of Aarhus
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2016-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00476541

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00476541, "NOPHO-AML 2004 Study for Children With Acute Myeloid Leukemia". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT00476541. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*